New eye drop shows promise for glaucoma control in chinese patients

NCT ID NCT06666855

Ongoing Disease control Sponsor: Santen Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new eye drop called DE-117B in 345 Chinese adults with open-angle glaucoma or high eye pressure. The goal is to see if it safely lowers eye pressure better than an existing drug. Participants use the drops once daily for at least 4 weeks, with long-term follow-up. This is a disease-control treatment, not a cure, so patients will need to keep using medication to manage their condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ocular hypertension open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OCULAR HYPERTENSION OPEN ANGLE GLAUCOMA

Contacts and locations

Show contact details

Locations

Affiliated Hospital of Guizhou Medical University

Guiyang, China
Aier Eye Hospital (Liaoning)

Shenyang, China
Beijing Chao-Yang Hospital, Capital Medical University

Beijing, China
Beijing Hospital

Beijing, China
Beijing Tongren Hospital, Capital Medical University

Beijing, China
Daqing People's Hospital

Heilongjiang, China
Jinan Second People's Hospital (Jinan eye hospital)

Jinan, China
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Shantou, China
Luoyang third people's hospital

Luoyang, China
Peking University Third Hospital

Beijing, China
Qingdao Eye Hospital of Shandong First Medical University

Qingdao, China
Shanghai Eye Disease Prevention And Treatment Center/Shanghai Eye Hospital

Shanghai, China
Shanxi eye hospital

Shanxi, China
Shenzhen Eye Hospital

Shenzhen, China
The 4th People's Hospital of Shenyang

Shenyang, China
The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, China
The Second Hospital & Clinical Medicial Lanzhou University

Lanzhou, China
Tianjin Eye Hospital

Tianjin, China
Wuhan Aier Eye Hospital

Wuhan, China
Wuhan Puren Hospital

Wuhan, China
Wuxi Second People's Hospital

Wuxi, China
Zhejiang Provincial People's Hospital

Hangzhou, China
Zhongnan Hospital Affiliated to Wuhan University

Wuhan, China
Zhongshan Ophthalmic Center

Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.